Home › Funds › Long Path Partners LP › MLAB

Long Path Partners LP position in MLAB

MESA LABORATORIES INC · Industrials

Long Path Partners LP reported holding 477,126 shares of MLAB (MESA LABORATORIES INC) in its Q2 2026 13F filing — a position valued at US$47.5M, representing 20.24% of its reported portfolio and ranking #2 among its reported holdings. Long Path Partners LP has disclosed MLAB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)477.13K sh
Reported value held$47.50M
Portfolio Weight20.24%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Long Path Partners LP's MLAB position evolved

Long Path Partners LP first disclosed a stake in MLAB in Q4 2025 at 227,223 shares (US$17.8M). The position peaked in Q2 2026 at 477,126 shares, worth US$47.5M. Across 3 filings, Long Path Partners LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 477,126 shares valued at US$47.5M — an increase of 71,543 shares quarter over quarter.. Notable position changes include a 78% increase in Q1 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 227.22K $17.84M New
Q1 2026 405.58K $35.86M Add
Q2 2026 477.13K $47.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLAB and 13F data

MLAB (MESA LABORATORIES INC) is a Industrials company. 29 other funds we track also report a position in MLAB — the largest reported positions include Ranger Investment Management, L.P. (US$17.3M), Meros Investment Management, LP (US$6.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLAB

All MLAB fund holders →

FAQ

How long has Long Path Partners LP held MLAB?

Long Path Partners LP has disclosed MLAB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Long Path Partners LP's current position in MLAB?

As of Q2 2026, Long Path Partners LP holds 477.13K shares of MLAB (MESA LABORATORIES INC), valued at $47.50M, representing 20.24% of its reported portfolio and ranking #2.

Has Long Path Partners LP been buying or selling MLAB?

In the latest 13F filing (Q2 2026), Long Path Partners LP increased its position in MLAB. The position peaked in Q2 2026 at 477.13K shares.

Which other funds hold MLAB?

Other major institutional holders of MLAB include Ranger Investment Management, L.P., Meros Investment Management, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.